Zhang, J.; Zhang, P.; Zou, Q.; Li, X.; Fu, J.; Luo, Y.; Liang, X.; Jin, Y.
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment. Molecules 2018, 23, 2906.
https://doi.org/10.3390/molecules23112906
AMA Style
Zhang J, Zhang P, Zou Q, Li X, Fu J, Luo Y, Liang X, Jin Y.
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment. Molecules. 2018; 23(11):2906.
https://doi.org/10.3390/molecules23112906
Chicago/Turabian Style
Zhang, Jing, Peng Zhang, Qian Zou, Xiang Li, Jianjiang Fu, Ying Luo, Xinli Liang, and Yi Jin.
2018. "Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment" Molecules 23, no. 11: 2906.
https://doi.org/10.3390/molecules23112906
APA Style
Zhang, J., Zhang, P., Zou, Q., Li, X., Fu, J., Luo, Y., Liang, X., & Jin, Y.
(2018). Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment. Molecules, 23(11), 2906.
https://doi.org/10.3390/molecules23112906